Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: FTSE +0.2%, DAX +0.1%, CAC flat

Oct 29 ,2026

  • Synopsis

    • European equity markets set to open broadly flat to higher, with focus on earnings newsflow and ECB decision. Asia equities mixed Thursday. AI sentiment turning cautious again following overnight continuation of positive momentum. Samsung (005930.KS) earnings were in line with preliminary figures though with some variation in consensus. Sharp selloff attributed more to its announcement that a new shareholder return plan in January rather than now. Upgraded capex plans also fed into broader caution over AI spending. Results combined with weaker US after-hours earnings. Alphabet (GOOGL) dropped 10% after headline metrics disappointed while FCF negative for a second straight quarter as CFO Ashkenazi signaled 'significant' capex growth in 2027. ServiceNow (NOW) tumbled 18% as in-line Q4 revenue guidance was met with a high-bar. Reactions well exceeded strength in Microsoft (MSFT) after earnings beat. However, lower than expected capex pressured neoclouds.

    • Fed's on-hold decision was widely expected though with inflation commentary remaining hawkish and two dissenters (Cook, Hammack) calling for a hike. December rate hike expectations remain intact though futures dialing back a third move next year. Attention drawn to Warsh's announcement of a gradual reduction in the number of rate-setting votes over the next two years, reserving one of the eight meetings next year for broad monetary policy strategy discussions with no vote (two in 2028).

    • Busy session for earnings/updates in the region with broadly positive results across European financials and industrials. Societe Generale (GLE.FP) was a standout, posting Q3 net income of €1.89B well ahead of the €1.62B consensus and flagging it's on track to exceed 2026 targets. STMicro (STMPA.FP) with mixed Q3 but Q4 2026 guidance above expectations, with gross margin beat. Aker BP (AKRBP.NO) massively beat Q3 EPS expectations on back of impairment reversal, while Prysmian (PRY.IM) raised FY26 guidance and said it will beat its 2028 financial targets two years ahead of schedule. ING Groep (INGA.NA) reported mixed Q3 but announced a €1.9B shareholder distribution. AB InBev (ABI.BB) beat on EPS and confirmed guidance (China offset decent results elsewhere). In a significant strategic development, Deutsche Telekom has paused plans to merge with T-Mobile US (TMUS), while BP (BP.LN) attracted attention on reports that certain board members may favour a company break-up. Today's big reporters include Volkswagen (VOW3.GR), Adidas (ADS.GR), TotalEnergies (TTE.FP), Shell (SHEL.LN), Lloyds Banking Group (LLOY.LN), Glencore (GLEN.LN) and Neste (NESTE.FH). Notable broker moves include ABB (ABB.SS) upgraded to Buy at SEB, Aker Solutions (AKSO.NO) upgraded across multiple brokers, and Vonovia (VNA.GR) cut to Neutral at Oddo after the guidance for 2026 and 2028 was lowered.

    • European macro data releases include Italy Oct business/consumer confidence, Sep unemployment rate, Spain Sep retail sales, UK Sep mortgage approvals, M4 money supply, Eurozone Oct economic/industrial/service sentiment, Belgium Q3 preliminary GDP, Oct CPI, Sep unemployment rate, Sweden Q3 preliminary GDP, Sep retail sales, Ireland Q3 preliminary GDP

    • In central banks, ECB interest rate decision at 14:15CET and press conf. at 14:45. The benchmark interest rate is expected to be left unchanged at 2.65%. EU's Cipollone remarks at event titled 'One year to T+1' organised by the EU T+1 Industry Committee. Austria central bank's Kocher introductory remarks at 17:00CET, Netherlands central bank's Sleijpen panellist at event title Energy crisis - an opportunity for clean energy transition? SNB money market event speakers include SNB's Tschudin and Moser at 18:30CET. Belgium central bank's Wunsch speech at 18:30GMT on Europe's economic challenges at event hosted by the European Institute and OMFIF. Bank of Italy/ECB co-host 5th Conf on 'Foreign Trade, Value Chains, and Financial Linkages in the Global Economy' (through Fri).

    • In politics, there's EU-Canada summit (through Fri) attendees/participants include EU's von der Leyen, Costa, Šefčovič and Kallas. EU's von der Leyen delivers a keynote speech on EU-Canada relations at the C.D. Howe institute. Meeting of EU energy ministers takes palce. Chancellor Merz meets with South Korea's President Lee Jae-myung. In the UK, after questions on transport, MPs continue to debate the budget. EU's Zaharieva speech at the Crossroads Startup event, also takes part in the EIC Info Day, participates in EURAXESS Biennial Conf as well as participates in a joint session of two committees of the Bulgarian National Assembly. Institute for Fiscal Studies (IFS) Autumn Budget 2026 analysis at 10:30GMT. UK Sep car production.

  • Top company news

    • Earnings/updates

      • Benelux

        • ABI.BB (Anheuser-Busch InBev) -- reports Q3 Underlying EPS $1.21 vs consensus $1.15; confirms FY guidance

        • INGA.NA (ING Groep) -- reports Q3 net income €1.85B vs consensus €1.94B; well on track to deliver on 2026 outlook; announces shareholder distribution of up to €1.9B

        • CTPNV.NA (CTP NV) -- reports 9M EPRA EPS €0.75 vs year-ago €0.70; reiterates FY adj. EPRA EPS guidance

      • France

        • STMPA.FP (STMicroelectronics) -- reports Q3 non-GAAP EPS $0.37 vs consensus $0.39; guides Q4

        • AIR.FP (Airbus SE) -- reports Q3 adj. EBIT €1.77B vs consensus €1.78B; 2026 guidance unchanged

        • DBV.FP (DBV Technologies) -- reports Q3 EPS ($0.14) vs FactSet ($0.18) [2 est, ($0.26)-(0.09)]

        • RNO.FP (Renault) -- reports Q3 revenue €11.60B vs consensus €11.39B

        • AI.FP (Air Liquide) -- reports Q3 revenue €7.26B vs consensus €7.16B; FY26 and FY27 outlook confirmed

        • GLE.FP (Societe Generale) -- reports Q3 net income €1.89B vs consensus €1.62B; On track to exceed 2026 targets

        • ELIS.FP (Elis) -- reports Q3 revenue €1.32B vs FactSet €1.32B [2 est, €1.32-1.32B]; FY guidance confirmed

        • BB.FP (Bic) -- reports Q3 revenue €516M vs consensus €507.0M

        • SOP.FP (Sopra Steria Group) -- reports Q3 revenue €1.42B vs FactSet €1.36B [1 est]..Raises FY target for organic revenue growth

        • LSS.FP (Lectra) -- reports Q3 net income €10.4M vs year-ago €7.2M

        • CLARI.FP (Clariane) -- reports Q3 revenue €1.35B, +2% vs year-ago €1.32B

        • VETO.FP (Vetoquinol) -- reports Q3 revenue €139.7M, +10% vs year-ago €126.6M

        • MRN.FP (Mersen) -- reports Q3 revenue €329.2M vs FactSet €310.0M [1 est]

        • PLX.FP Pluxee reports FY adj net income €223M vs FactSet €214.8M; hikes divi by 71% and guides FY27

        • VANTI.FP (Vantiva) -- reports Q3 revenue €436M, (7%) vs year-ago €470M

      • Southern Europe

        • BBVA.SM (BBVA) -- reports Q3 net attributable profit €3.02B vs consensus €3.01B (

        • CPR.IM (Davide Campari-Milano) -- reports Q3 revenue €777M vs StreetAccount €764.8M; confirms FY outlook

        • PRY.IM (Prysmian) -- reports Q3 net income €408M vs FactSet €410.6M [6 est, €368-512.1M]; FY26 guide raised; to beat 2028 financial targets two years ahead of schedule (

        • SAB.SM (Banco de Sabadell) -- reports Q3 net income €405M vs consensus €376M

        • BCP.PL (Banco Comercial Portugues) -- reports 9M net income €873.7M, +13% vs year-ago €775.9M

        • JMT.PL (Jeronimo Martins) -- reports Q3 EPS €0.34 ex-items vs StreetAccount €0.31

      • DACH

        • WCH.GR (Wacker Chemie) -- reports Q3 EBIT €102.8M vs FactSet €100.0M [1 est]; reaffirms FY guidance except for annual net financial debt

        • IDIA.SW (Idorsia) -- reports Q3 Non-GAAP net income (CHF44M) vs FactSet (CHF52.5M) [2 est, (CHF61.0)-(44M)]; FY26 guidance reaffirmed

        • AVOL.SW (Avolta) -- reports Q3 CORE revenue CHF4.00B vs StreetAccount CHF3.91B

        • KGX.GR (Kion Group) -- reports final Q3 earnings: EPS €0.76 vs FactSet €0.74 [8 est, €0.62-0.85]

        • VNA.GR (Vonovia) -- provides guidance update

        • VNA.GR (Vonovia) -- Follow-up: Vonovia updates long term 2028 Objectives

        • AIXA.GR (Aixtron) -- reports Q3 EPS €0.31 vs FactSet €0.31 [5 est, €0.29-0.33]; FY26 guidance confirmed; strong outlook for 2027 (€31.47)

        • ANDR.AV (Andritz) -- reports Q3 net income €127.3M vs consensus €118.6M; confirms FY guidance

        • KBX.GR (Knorr-Bremse) -- reports Q3 Operating EBIT €299M vs FactSet €291.9M [8 est, €223.2-305.3M]

        • OMV.AV (OMV) -- reports Q3 Clean CCS net income attributable €1.15B vs consensus €1.09B (€72.75)

        • VONN.SW (Vontobel) -- Holding 9M Trading Update: Assets under management CHF 255.1B at end of Sep vs 252.2B at end of H1

        • RDC.GR (Redcare Pharmacy) -- reports Q3 adjusted EBITDA €29M vs FactSet €23.6M [3 est, €17.5-30M]; confirms FY guidance

        • SZG.GR (Salzgitter) -- provides prelim financials for first nine months of 2026 and upward revision of annual guidance

      • Nordics

        • DANSKE.DC (Danske Bank) -- reports Q3 EPS DKK7.90 vs consensus DKK7.30; narrows FY26 outlook

        • AKRBP.NO (Aker BP) -- reports Q3 EPS $1.56 vs FactSet $0.94 [11 est, $0.78-1.05]

        • BINV.SS (BioInvent International) -- reports Q3 EPS (SEK1.81) vs year-ago (SEK1.96); plans new share issue worth ~SEK430M

        • DNORD.DC (D/S Norden) -- reports Q3 net income $53.9M vs year-ago $26M

        • AOJ.B.DC (Brødrene A & O Johansen) -- reports Q3 pretax income DKK57.2M vs FactSet DKK65M; FY guidance raised

        • EPR.NO (Europris) -- reports Q3 EPS NOK0.79 vs FactSet NOK0.93 [5 est, NOK0.86-1.00]

        • KOG.NO (Kongsberg Gruppen) -- reports Q3 EPS continuing ops NOK1.69 vs FactSet NOK1.62 [6 est, NOK1.54-1.76]

        • KESKOB.FH (Kesko) --reports Q3 comparable EPS €0.40 vs FactSet €0.39 [5 est, €0.38-0.39]; updates 2026 profit guidance

      • Also reporting today

        • Earnings: Austria: AMAG Austria Metall (AMAG.AV) Belgium: Denmark: Netcompany Group (NETC.DC), Tivoli (TIV.DC) Finland: Neste (NESTE.FH), Kesko (KESKOB.FH), Huhtamaki (HUH1V.FH), Kalmar (KALMAR.FH), Alma Media (ALMA.FH), Metsa board (METSB.FH), Qt Group (QTCOM.FH), Harvia (HARVIA.FH), Posti Group (POSTI.FH), Enento Group (ENENTO.FH), Etteplan (ETTE.FH), Oriola (ORIOLA.FH), Loihde (LOIHDE.FH) France: TotalEnergies (TTE.FP), Amundi (AMUN.FP), Ayvens (AYV.FP), Technip Energies (TE.FP), Imerys (NK.FP), TF1 (TFI.FP), X-FAB Silicon Foundries (XFAB.FP), 2CRSI (AL2SI.FP), MEDIAN Technologies (ALMDT.FP), Lhyfe (ALHYF.FP) Germany: Volkswagen (VOW3.GR), Adidas (ADS.GR), MTU Aero Engines (MTX.GR), AlzChem Group (ACT0.GR), Befesa (BFSA.GR), Drägerwerk (DRW3.GR), LPKF Laser & Electronics (LPK.GR), Baader Bank (BWB.GR) Italy: Italgas (IG.IM), Amplifon (AMP.IM), Elica (ELC.IM) Netherlands: Universal Music Group (UMG.NA), Eurocommercial Properties (ECMPA.NA) Norway: DNO (DNO.NO), Sparebanken Norge (SBNOR.NO), SpareBank 1 SMN (MING.NO), SpareBank 1 Nord-Norge (NONG.NO), Sparebanken Møre (MORG.NO), BW Energy (BWE.NO), Elkem (ELK.NO), Aker BioMarine (AKBM.NO), Smartoptics Group (SMOP.NO), Pareto Bank (PARB.NO), Axactor (ACR.NO), Appear (APR.NO), Vistin Pharma (VISTN.NO) Other: Íslandsbanki (ISB.IR) Spain: Repsol (REP.SM), Naturgy Energy Group (NTGY.SM), Indra Sistemas (IDR.SM), Fluidra (FSM), Global Dominion Access (DOM.SM) Sweden: Boliden (BOL.SS), Sweco (SWEC.B.SS), Paradox Interactive (PDX.SS), Nolato (NOLA.B.SS), Troax Group (TROAX.SS), engcon (ENGCON.B.SS), Tången Industrikapital (TANGEN.B.SS), CellaVision (CEVI.SS), Eltel (ELTEL.SS), XANO Industri (XANO.B.SS), Net Insight (NETI.B.SS), CTEK (CTEK.SS), Senzime (SEZI.SS), Scandinavian Enviro Systems (SES.SS) Switzerland: Landis+Gyr Group (LAND.SW) UK: Shell (SHEL.LN)

        • Trading Update: Benelux: Flow Traders (FLOW.NA), Recticel (RECT.BB) DACHs: Molecular Partners (MOLN.SW), lastminute.com (LMN.SW) France: AXA (CS.FP), Eutelsat Communications (ETL.FP), Emeis SA (EMEIS.FP), Eramet (ERA.FP), 74Software (74SW.FP), Manitou BF (MTU.FP), Wavestone (WAVE.FP), Equasens Group (EQS.FP), Groupe Samse (SAMS.FP), Adocia (ADOC.FP) Nordics: Carlsberg (CARL.B.DC), Bittium (BITTI.FH), Detection Technology (DETEC.FH), Rapala VMC (RAP1V.FH), Minesto (MINEST.SS) Southern Europe: Seri Industrial (SERI.IM) UK: Glencore (GLEN.LN), Lloyds Banking Group (LLOY.LN), Haleon (HLN.LN), IMI (IMI.LN), St. James's Place (STJ.LN), WPP Group (WPP.LN), PPHE Hotel Group (PPH.LN), ASA International Group (ASAI.LN)

        • CMD/Events: Elkem (ELK.NO), Appear (APR.NO), Banca Monte dei Paschi di Siena (BMPS.IM) EGM, MPC Container Ships (MPCC.NO) EGM, Sparebanken Norge (SBNOR.NO) EGM

    • M&A

      • TMUS (T-Mobile US) -- Deutsche Telecom pauses plans to merge with T-Mobile US - Bloomberg

      • TECK.B.CN (Teck Resources) -- reports Q3 EPS C$1.88 vs FactSet C$1.59 [14 est, C$0.64-1.63]

      • AES (AES Corp.) -- discloses European Commission closes its preliminary review of its acquisition by consortium led by Global Infrastructure Partners and EQT - 8-K

      • SPIE.FP (SPIE) -- signs an agreement for the acquisition of SAR ANLAGENBAU GmbH in Austria and Germany

      • EUROB.GA (Eurobank SA) -- Fairfax completes sale of 80% interest in Eurolife to Eurobank; deal was announced 13-Oct-2025

    • Healthcare

      • KYMR (Kymera Therapeutics) -- to announce KT-579 Phase 1 healthy volunteer trial results on 29-Oct-26

      • GMAB.DC (Genmab) -- Transcript Intelligence: Genmab Business Update Call

      • DBV.FP (DBV Technologies) -- SEC filing: 10-Q

      • IDIA.SW (Idorsia) -- and SPV investors partner to unlock the blockbuster potential of TRYVIO/JERAYGO with a targeted launch in specialists

      • BINV.SS (BioInvent International) -- to carry a new issue of shares of ~SEK430M

      • ONCIN.NO (Oncoinvent) -- Transcript Intelligence: Oncoinvent Business Update Call

    • Other

      • BP.LN (BP) -- Certain BP board members may favor company split -- Semafor

      • RR.LN (Rolls-Royce Holdings) -- announces transformative jet engine technology programme

      • DG.FP (VINCI SA) -- awarded €149M contract Sinfonia Varsovia Centrum

      • EDEN.FP (Edenred) -- enters new share buyback mandate for max amount of €50M

      • GFC.FP (Gecina) -- signed 10,300 sq.m with a global tech and data infrastructure security company on the 16 Capucines asset

      • AVIO.IM (Avio) -- obtains new €55M order from MBDA in France

      • Fed leaves rates unchanged despite inflation concerns; Tesla Semi fire shuts down California freeway in intraday themes (28-Oct)

  • Key rating changes

    • Upgrades

      • Morgans upgrades BHP.AU, RIO.AU

      • ABB.SS (ABB Limited) -- to buy from hold at SEB

      • AKSO.NO (Aker Solutions) -- to buy from hold at Pareto

      • AKSO.NO (Aker Solutions) -- to hold from sell at Danske Bank

      • AKSO.NO (Aker Solutions) -- to hold from sell at SEB

      • AKSO.NO (Aker Solutions) -- to neutral from sell at Sparebank 1 Markets

      • SSAB.A.SS (SSAB) -- to buy from hold at DNB Carnegie

    • Downgrades

      • CRBN.NA (Corbion) -- to hold from buy at Berenberg

      • GMAB.DC (Genmab) -- to hold from buy at DNB Carnegie

      • VNA.GR Vonovia downgraded to neutral from outperform at Oddo

  • Data

    • Nikkei +1.10% to 64659.47

    • Hang Seng (0.22%) to 23044.04

    • Shanghai Composite (0.88%) to 3648.97

    • S&P futures (25.3) vs prior close of 7783.3

    • €-$ (0.0016) or (0.14%) to 1.1139

    • $-¥ (0.02) or (0.01%) to 157.81

    • €-¥ (0.27) or (0.15%) to 175.77

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.